UTHR News and Press, United Therapeutics Corporation From 08/01/22

Shares of MannKind Corporation (NASDAQ: MNKD) , a biotech company that specializes in finding therapies for endocrine and orphan lung diseases, rose 10.4% on Monday. The stock closed at $3.45 on Friday and opened at that price on Monday. A little after 11 a.m., the stock reached its...

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its second quarter 2022 financial results before the market opens on Wednesday, August 3, 2022. United Therapeutics will host a public webcast Wednesday, August 3, 2022, at 9:00 a.m. Eastern Time. The...

Ladenburg Thalmann has initiated Liquidia Corp. ( NASDAQ: LQDA ) with a buy citing the potential of the company's lead asset, Yutrepia, for pulmonary arterial hypertension (PAH). Shares are up 7% in Friday morning trading. Yutrepia is a dry inhalation powder v...

Liquidia ( NASDAQ: LQDA ) climbed as much as 16.2% to hit a 2-month high on Friday after Ladenburg Thalmann began coverage of the stock with a Buy rating. The brokerage set a $15 price target on LQDA, implying potential upside of 198.2% to its last close. "We belie...

United Therapeutics (UTHR) is a biotechnology company that was founded by Dr. Martine Rothblatt with the intent of finding a cure for her daughter’s rare condition, explains Tony Sagami, editor of Weiss Ultimate Portfolio. For further details see: United Therapeutics- A Bargain i...

Shares of United Therapeutics ( NASDAQ: UTHR ) reached an all-time high Wednesday of $244.80. Year to date, the stock is up ~15% . United Therapeutics ( UTHR ) was buoyed by the May U.S. FDA approval of Tyvaso DPI (treprostinil) for pulmonary arterial hype...

The eleven sectors of the S&P 500 were 16.4% lower for Q2 2022, with SPDR S&P 500 Trust ETF closed more than 16% lower . The top five gainers in the health care sector (stocks with a market cap of over $2B) were: Turning Point Therapeutics ( TPTX ) +179.1...

Plans are underway at the Food and Drug Administration (FDA) to allow clinical studies testing the transplantation of pig organs into humans, The Wall Street Journal reported, citing a person familiar with the matter. Several research teams have recently sought FDA guidance on how t...

I will share the pros and cons of the coming battle these two companies will face in gaining market share with their competing drug. I will identify who I think will be winning this battle. Key caveat for who I think will win will be shared. For further details see: ...

Benefit corporations are a new form of business and increasing in number on the market. Similar to ESG metrics, these companies often take it many steps further in regards to positivity. The business structure allows some profits to be syphoned away towards beneficial endeavors, w...